BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 13, 2005
View Archived Issues
Novel peptide enhances the effects of BMP-2 in vitro
Read More
Antisoma to acquire Aptamera
Read More
Isis restructures
Read More
Lexicon advances two drug discovery programs into preclinical development
Read More
Millennium reviews 2004 milestones, looks forward to 2005
Read More
Phase III study planned for Mylinax in MS
Read More
RC-1291 receives fast track designation for cancer anorexia/cachexia
Read More
Taxotere approved for two new indications in Europe
Read More
Unique dual-binding AChE inhibitor with potent Abeta antiaggregating activity
Read More
European Rotarix filing sparks milestone payment to Avant
Read More
Biolex seeks approvals for phase I trials of BLX-883
Read More
Spectrum completes enrollment of phase II EOquin trial
Read More
Traficet-EN studied in phase II for IBD
Read More
GX15-070 enters phase I/II trial in CLL, receives orphan drug status
Read More
Aventis Pasteur changes name to sanofi pasteur
Read More
Samaritan drives progress of SP-01A for HIV
Read More
Raven Biotechnologies begins phase I/IIa trial of RAV-12 in GI cancers
Read More
TRU-015 enters phase I for rheumatoid arthritis
Read More
Phase II data on the efficacy of squalamine in wet AMD
Read More
A valopicitabine plus pegylated interferon regimen shows promise in hepatitis C
Read More
Juvantia develops a novel superagonist of human somatostatin receptor subtype 4
Read More
CB-03-01: a novel, selective androgen antagonist for topical use
Read More
Novel dual pharmacophore directly modulates cardiac function
Read More
Amgen's thrombopoietin receptor ligand AMG-531 tested in healthy individuals
Read More
New agents for Alzheimer's disease claimed by De Novo
Read More
Antibacterial ketolides described by Chiron scientists
Read More
Researchers at Actelion disclose orexin receptor antagonists
Read More
GSK team identifies new 5-HT5A receptor ligands for CNS disorders
Read More
HIV integrase inhibitors in early development at Bristol-Myers Squibb
Read More
Roche scientists prepare and test new agents for cancer
Read More
Antiinfective agents claimed by GlaxoSmithKline
Read More